Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Introduction:
During their lifetime, 75%–80% of CD patients will require surgical intervention, (1, 3) most commonly ileocecal resection (ICR). (2, 4)
Furthermore, 75%–80% of pts experience endoscopic recurrence of disease, usually in the neoterminal ileum, proximal to the surgical anastomosis (1–3,5).
Pts with CD have an altered gut microbiome composition compared with healthy controls, characterized by decreased bacterial diversity and alterations in bacterial composition, including increased abundances of potentially harmful bacteria and decreased abundances of protective bacteria. (6–9)
More specifically, the altered mucosal microbiome in the ileal mucosa of CD patients is characterized by increased abundances of Proteobacteria and Fusobacteria phyla, in addition to Enterobacteriaceae, Veillonellaceae…